share_log

Conduit Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Polar Asset Management Partners Inc.(1.3%)

Conduit Pharmaceuticals | SC 13G/A：超過5%持股股東披露文件(修正)-Polar Asset Management Partners Inc.(1.3%)

美股SEC公告 ·  02/12 12:56

Moomoo AI 已提取核心訊息

Polar Asset Management Partners Inc., an investment fund manager based in Ontario, Canada, has filed an amended Schedule 13G/A with the Securities and Exchange Commission on February 12, 2024, indicating a change in its holdings in Conduit Pharmaceuticals. The filing reveals that Polar Asset Management now beneficially owns 950,000 shares of Conduit Pharmaceuticals, which are issuable upon the exercise of warrants, representing 1.3% of the company's class of common stock. This stake is solely managed by Polar Asset Management, with no shared voting or dispositive power. The filing, dated December 31, 2023, also certifies that the shares were not acquired for the purpose of changing or influencing the control of Conduit Pharmaceuticals.
Polar Asset Management Partners Inc., an investment fund manager based in Ontario, Canada, has filed an amended Schedule 13G/A with the Securities and Exchange Commission on February 12, 2024, indicating a change in its holdings in Conduit Pharmaceuticals. The filing reveals that Polar Asset Management now beneficially owns 950,000 shares of Conduit Pharmaceuticals, which are issuable upon the exercise of warrants, representing 1.3% of the company's class of common stock. This stake is solely managed by Polar Asset Management, with no shared voting or dispositive power. The filing, dated December 31, 2023, also certifies that the shares were not acquired for the purpose of changing or influencing the control of Conduit Pharmaceuticals.
總部位於加拿大安大略省的投資基金管理公司Polar Asset Management Partners Inc. 已於2024年2月12日向美國證券交易委員會提交了經修訂的附表13G/A，表明其持有的Conduit Pharmicals發生了變化。該文件顯示，Polar資產管理公司現在實益擁有Conduit Pharmicals的95萬股股票，這些股票可在行使認股權證時發行，佔公司普通股類別的1.3％。該股權完全由Polar資產管理公司管理，沒有共同的投票權或處置權。這份日期爲2023年12月31日的文件還證明，收購這些股票不是爲了改變或影響Conduit Pharmicals的控制權。
總部位於加拿大安大略省的投資基金管理公司Polar Asset Management Partners Inc. 已於2024年2月12日向美國證券交易委員會提交了經修訂的附表13G/A，表明其持有的Conduit Pharmicals發生了變化。該文件顯示，Polar資產管理公司現在實益擁有Conduit Pharmicals的95萬股股票，這些股票可在行使認股權證時發行，佔公司普通股類別的1.3％。該股權完全由Polar資產管理公司管理，沒有共同的投票權或處置權。這份日期爲2023年12月31日的文件還證明，收購這些股票不是爲了改變或影響Conduit Pharmicals的控制權。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間